Discovery of CVN417, a Novel Brain-Penetrant a6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.3c00630

PubMed Identifier: 37651656

Publication URI: http://europepmc.org/abstract/MED/37651656

Type: Journal Article/Review

Volume: 66

Parent Publication: Journal of medicinal chemistry

Issue: 17

ISSN: 0022-2623